Table 3.
Early Immunoparalysis Was Associated with Increased Hospital Mortality in Elderly Patients
| Subgroup | Model 1 | Model 2a | Model 3b |
|---|---|---|---|
| Non-elderly | |||
| Sample size (n) | 92 | 92 | 80 |
| Early immunoparalysis | 1.425 (0.434–4.676) | 1.074 (0.242–4.763) | 1.604 (0.351–7.331) |
| Immune status improvement | – | – | 0.131 (0.029–0.584) |
| Elderly | |||
| Sample size (n) | 181 | 181 | 159 |
| Early immunoparalysis | 2.382 (1.257–4.514) | 2.257 (1.130–4.506) | 2.684 (1.224–5.883) |
| Immune status improvement | – | – | 0.335 (0.159–0.706) |
Notes: Values are odds ratios (95% confidence intervals) unless stated otherwise. aAdjusted for sex, age (per 10 years), pre-existing condition, immunotherapy, and SOFA score (high vs low). bAdjusted for covariates in model 2 and the dichotomous variable of immune status improvement on day 3 (yes vs no).